Rezolute, Inc. is downgraded to a Sell after its phase 3 sunRIZE trial for congenital hyperinsulinism failed. Learn more ...
AI initiatives don’t stall because models aren’t good enough, but because data architecture lags the requirements of agentic systems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results